Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-023533)

Filing Details

Accession Number:: 0001209191-17-023533
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-29 16:54:08
Reporting Period:: 2015-03-16

Filing Date:: 2017-03-29
Accepted Time:: 2017-03-29 16:54:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1044378	Biocept Inc	BIOC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1026765	Ivor Royston	C/O Biocept, Inc. 5810 Nancy Ridge Drive #150 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-03-16	5,667	$8.76	17,294	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 34,584 fewer shares.
The number of shares and purchase price shown in column 4 above are reflected on a post-split basis.
The number of shares reflected in column 5 above reflects the Reporting Person's ownership as of March 29, 2017.